Charles Schwab Investment Management Inc. Sells 47,103 Shares of Embecta Corp. $EMBC

Key Points

• Charles Schwab Investment Management Inc. reduced its stake in Embecta Corp. by 6.0%, owning approximately 1.26% of the company after selling over 47,000 shares in the first quarter.
• Several institutional investors are actively adjusting their positions in Embecta, with Jefferies Financial Group increasing its holdings by 60.1% during the same period.
• Embecta Corp. recently announced a quarterly dividend of $0.15 per share, marking a 4.2% yield based on an annualized dividend of $0.60.

Charles Schwab Investment Management Inc. cut its holdings in Embecta Corp. (NASDAQ:EMBC - Free Report) by 6.0% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 735,087 shares of the company's stock after selling 47,103 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 1.26% of Embecta worth $9,372,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Ameriflex Group Inc. acquired a new stake in Embecta in the fourth quarter valued at about $53,000. Siemens Fonds Invest GmbH acquired a new stake in Embecta in the fourth quarter valued at about $77,000. Wealthquest Corp acquired a new stake in Embecta in the first quarter valued at about $48,000. Picton Mahoney Asset Management acquired a new stake in Embecta in the first quarter valued at about $50,000. Finally, Tower Research Capital LLC TRC boosted its stake in Embecta by 111.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,284 shares of the company's stock valued at $150,000 after buying an additional 3,835 shares in the last quarter. 93.83% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms recently weighed in on EMBC. Wall Street Zen raised Embecta from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 16th. Zacks Research upgraded Embecta from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, August 26th. Mizuho dropped their target price on Embecta from $13.00 to $12.00 and set a "neutral" rating for the company in a research report on Wednesday, July 16th. Finally, BTIG Research set a $25.00 target price on Embecta and gave the company a "buy" rating in a research report on Friday, May 23rd. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $19.00.

Embecta Stock Down 0.1%

Embecta stock traded down $0.02 during trading hours on Friday, hitting $14.48. The stock had a trading volume of 366,799 shares, compared to its average volume of 688,264. The stock has a market cap of $846.94 million, a price-to-earnings ratio of 10.13, a P/E/G ratio of 0.80 and a beta of 1.11. Embecta Corp. has a one year low of $9.20 and a one year high of $21.48. The business's 50 day simple moving average is $11.41 and its 200-day simple moving average is $11.87.

Embecta (NASDAQ:EMBC - Get Free Report) last posted its quarterly earnings data on Friday, August 8th. The company reported $1.12 EPS for the quarter, topping analysts' consensus estimates of $0.77 by $0.35. The company had revenue of $295.50 million for the quarter, compared to analyst estimates of $278.15 million. Embecta had a negative return on equity of 23.40% and a net margin of 7.58%.The firm's quarterly revenue was up 8.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.74 earnings per share. Embecta has set its FY 2025 guidance at 2.900-2.950 EPS. Research analysts anticipate that Embecta Corp. will post 2.85 EPS for the current fiscal year.

Embecta Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Investors of record on Friday, August 29th will be paid a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 4.1%. The ex-dividend date of this dividend is Friday, August 29th. Embecta's payout ratio is currently 41.96%.

Embecta Company Profile

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.